石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01093 石药集团

交易中 03-23 10:56:18

8.310

-0.490

-5.57%

最高8.680	最低8.310	成交量3,311万
今开8.640	昨收8.800	日振幅4.20%
总市值957.48亿	流通市值957.48亿	总股本115.22亿
成交额2.79亿	换手率0.29%	流通股本115.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"石药集团","latestPrice":8.31,"timestamp":1774234576103,"preClose":8.8,"halted":0,"volume":33112508,"delay":0,"changeRate":-0.0556818181818182,"floatShares":11522000000,"shares":11522000000,"eps":0.368718,"marketStatus":"交易中","change":-0.49,"latestTime":"03-23 10:56:18","open":8.64,"high":8.68,"low":8.31,"amount":279203623,"amplitude":0.042045,"askPrice":8.32,"askSize":422000,"bidPrice":8.31,"bidSize":678000,"shortable":3,"etf":0,"ttmEps":0.387158,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1774238400000},"marketStatusCode":2,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":8.8,"dividendRate":0.028857,"openAndCloseTimeList":[[1774229400000,1774238400000],[1774242000000,1774252800000]],"volumeRatio":1.72444,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.5629,"impliedVolPercentile":0.5854},"requestUrl":"/m/hq/s/01093","defaultTab":"news","newsList":[{"id":"2620878247","title":"石药集团(01093)：GLP-1/GIP受体双偏向性激动多肽长效注射液在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2620878247","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620878247?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:24","pubTimestamp":1774002289,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团开发的GLP-1/GIP受体双偏向性激动多肽长效注射液已获中国国家药品监督管理局批准，可在中国开展临床试验。SYH2082有望成为临床开发阶段具领先潜力的长效GLP-1/GIP受体双重偏向性激动剂，每月给药一次。依托本集团的长效制剂技术平台，SYH2082可实现月度给药，提高患者依从性与用药便捷性。在毒理学研究中， SYH2082的耐受性良好，未观察到显著不良反应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288170.HKD","LU1960683339.HKD","LU0880133367.SGD","LU1226288253.USD","LU0315179316.USD","BK1191","BK1521","BK4144","LU1951186391.HKD","BK1515","LU0067412154.USD","LU0140636845.USD","LU0314109678.HKD","LU0326950275.SGD","LU0501845795.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU1226287875.USD","LU1226287529.USD","LU1807302812.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1008478684.HKD","BK4590","LU1152091168.USD","LU1226287792.SGD","LU1328277881.USD","LU1813983027.USD","LU2039709279.SGD","IE0008368742.USD","LU1152091754.HKD","LU0072913022.USD","HK0000165453.HKD","GLP","IE0008369823.USD","01093","IE00BZ08YT58.USD","LU1993786604.SGD","SG9999004220.SGD","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"1189485112","title":"石药集团GLP-1/GIP受体双偏向激动剂多肽长效注射液获中国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1189485112","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189485112?lang=zh_cn&edition=full","pubTime":"2026-03-20 18:23","pubTimestamp":1774002191,"startTime":"0","endTime":"0","summary":"石药集团宣布，其自主研发的SYH2082注射液——一种GLP-1/GIP受体双偏向激动剂多肽长效制剂，正式获得中国国家药品监督管理局的临床试验许可。该创新药物针对代谢性疾病治疗领域，通过双重作用机制实现更优疗效，标志着企业在代谢类创新药研发取得重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU0314109678.HKD","IE00B543WZ88.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091168.USD","LU1328277881.USD","BK1521","LU1226288170.HKD","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU0072913022.USD","IE00BZ08YR35.GBP","LU0140636845.USD","LU0067412154.USD","IE00BZ08YT58.USD","LU1226287792.SGD","IE0008369823.USD","LU0880133367.SGD","LU1008478684.HKD","LU0326950275.SGD","LU1226287875.USD","LU1226287529.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1813983027.USD","IE00B031HY20.USD","LU1807302812.USD","BK1191","LU1226288253.USD","SG9999004220.SGD","LU1152091754.HKD","BK1515","LU0501845795.SGD","01093","LU0315179316.USD"],"gpt_icon":0},{"id":"2620725596","title":"*ST景峰最新公告：公司控股股东变更为石药控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620725596","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620725596?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:31","pubTimestamp":1773837079,"startTime":"0","endTime":"0","summary":"*ST景峰(000908.SZ)公告称，公司因执行重整计划，以原有总股本约8.8亿股为基数每10股转增10股，总股本增至约17.6亿股。本次转增股份已于3月17日完成过户，石药控股集团持股约4.57亿股（占总股本26%），成为公司第一大股东。公司控股股东由叶湘武变更为石药控股，实际控制人变更为蔡东晨。叶湘武及其一致行动人持股比例被动稀释至6.52%，长城资产持股7.60%。本次变更不影响公司正常经营。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800037964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1807302812.USD","IE00B543WZ88.USD","HK0000165453.HKD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226287875.USD","LU0072913022.USD","LU0315179316.USD","LU0067412154.USD","LU1226287529.USD","BK0239","LU1813983027.USD","LU0326950275.SGD","LU1226287792.SGD","LU1951186391.HKD","LU1152091168.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","SG9999004220.SGD","LU1960683339.HKD","01093","LU1226288253.USD","LU1008478684.HKD","LU0880133367.SGD","IE00B031HY20.USD","LU0501845795.SGD","IE0008368742.USD","LU1993786604.SGD","BK1521","LU0314109678.HKD","BK0056","000908","IE00BZ08YR35.GBP","BK1191","LU1328277881.USD","BK1515","LU0140636845.USD","IE00BZ08YS42.EUR","IE0008369823.USD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2620334992","title":"阿里健康首发石药集团抗纤维化药物伊络达® 为间质性肺病患者开辟院外新通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2620334992","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620334992?lang=zh_cn&edition=full","pubTime":"2026-03-18 15:54","pubTimestamp":1773820468,"startTime":"0","endTime":"0","summary":"3月18日，石药集团旗下用于治疗纤维化性间质性肺疾病的核心产品——乙磺酸尼达尼布软胶囊于阿里健康首发。此次登陆阿里健康，是其上市后首次拓展至院外电商渠道。这是间质性肺病患者最常描述的感受。数据显示，我国间质性肺病患者超百万，且发病率逐年上升。","market":"hk","thumbnail":"https://imgcloud.jrjimg.cn/2026/03/20260318155516591.png","type":0,"news_type":0,"thumbnails":["https://imgcloud.jrjimg.cn/2026/03/20260318155516591.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/03/18155456358002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1610","LU2039709279.SGD","BK1247","LU0314109678.HKD","IE00B543WZ88.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091168.USD","BK1502","LU1328277881.USD","BK1521","LU1226288170.HKD","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU0072913022.USD","IE00BZ08YR35.GBP","LU0140636845.USD","LU0067412154.USD","IE00BZ08YT58.USD","BK1589","LU1226287792.SGD","BK1189","IE0008369823.USD","LU0880133367.SGD","BK1584","BK1501","LU1008478684.HKD","LU0326950275.SGD","00241","LU0315179316.USD","LU1226287875.USD","LU1226287529.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","BK1615","BK1617","LU1813983027.USD","IE00B031HY20.USD","LU1807302812.USD","BK1571","BK1191","LU1226288253.USD","SG9999004220.SGD","LU1152091754.HKD","BK1515","LU0501845795.SGD","BK1591","01093","BK1142"],"gpt_icon":0},{"id":"1146795104","title":"财报前瞻｜石药集团本季度营收预计增31.04%，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1146795104","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146795104?lang=zh_cn&edition=full","pubTime":"2026-03-18 10:20","pubTimestamp":1773800448,"startTime":"0","endTime":"0","summary":"石药集团将于2026年03月25日发布最新季度财报，本文梳理市场一致预期、上季度关键指标与本季度核心看点，并聚焦机构观点与潜在驱动。市场目前一致预期本季度石药集团收入预计为人民币84.92亿元，同比增长31.04%，调整后每股收益预计为人民币0.14元，同比增长142.62%；由于缺乏对毛利率与净利率的明确预测，本文不展示相关预测信息。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜石药集团本季度营收预计增31.04%，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"gpt_icon":0},{"id":"2620416271","title":"石药集团一项创新研究成果在国际著名权威期刊Science Advances发表","url":"https://stock-news.laohu8.com/highlight/detail?id=2620416271","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620416271?lang=zh_cn&edition=full","pubTime":"2026-03-17 09:24","pubTimestamp":1773710693,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月17日，石药集团公众号消息，近日，由石药集团李春雷博士、苏晓晔博士，以及复旦大学甘建华教授作为共同通讯作者，祁思娴博士作为第一作者合作完成的一项关于基因编辑治疗转甲状腺素蛋白淀粉样变（ATTR）的研究成果，以研究论文形式发表在国际著名权威期刊ScienceAdvances。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603173674033713.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674033713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B543WZ88.USD","IE0008369823.USD","LU1960683339.HKD","LU1993786604.SGD","LU1152091754.HKD","IE00BZ08YR35.GBP","LU0326950275.SGD","BK1515","HK0000165453.HKD","LU1328277881.USD","LU1951186391.HKD","LU1807302812.USD","LU0067412154.USD","SG9999004220.SGD","LU0314109678.HKD","LU0501845795.SGD","BK1521","IE0008368742.USD","IE00B5MMRT66.SGD","BK1191","IE00BZ08YT58.USD","LU1226287529.USD","LU0880133367.SGD","01093","LU1226287792.SGD","LU1226287875.USD","LU1813983027.USD","LU0140636845.USD","LU1152091168.USD","LU0315179316.USD","LU2039709279.SGD","IE00BZ08YS42.EUR","LU1226288170.HKD","LU1226288253.USD","IE00B031HY20.USD","LU1008478684.HKD","LU0072913022.USD"],"gpt_icon":0},{"id":"2619518466","title":"石药集团(01093)：石药创新2025年度归母净亏损2.41亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619518466","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619518466?lang=zh_cn&edition=full","pubTime":"2026-03-16 21:26","pubTimestamp":1773667581,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团(01093)发布公告，公司附属公司石药创新制药股份有限公司(石药创新)于截至2025年12月31日止年度取得营业收入21.58亿元(人民币，下同)，同比增长8.93%;归属于上市公司股东的净亏损2.41亿元，上年同期净利润5372.6万元;基本每股亏损0.1731元。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"石药集团(01093)：石药创新2025年度归母净亏损2.41亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0067412154.USD","BK1515","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1226288253.USD","BK1191","LU2039709279.SGD","LU1226288170.HKD","LU1226287529.USD","LU0315179316.USD","LU1813983027.USD","IE00BZ08YS42.EUR","HK0000165453.HKD","LU1152091168.USD","LU1226287792.SGD","LU1993786604.SGD","IE00BZ08YT58.USD","LU0501845795.SGD","LU1951186391.HKD","LU0140636845.USD","LU0072913022.USD","IE0008369823.USD","IE00B543WZ88.USD","BK1521","LU0326950275.SGD","SG9999004220.SGD","IE00B5MMRT66.SGD","01093","LU0880133367.SGD","LU1960683339.HKD","IE0008368742.USD","LU1152091754.HKD","LU0314109678.HKD","LU1008478684.HKD","LU1226287875.USD","LU1807302812.USD"],"gpt_icon":0},{"id":"2619454011","title":"石药集团(01093)：高选择性PDE4B抑制剂(SYH2059吸入粉雾剂)在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2619454011","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619454011?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:51","pubTimestamp":1773658299,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，本集团开发的化药1类新药高选择性PDE4B抑制剂(该产品)已获中国国家药品监督管理局批准，可在中国开展临床试验。该产品是本集团一款全新的、具有完全自主知识产权的高活性与高选择性磷酸二酯酶 4B抑制剂。本次获得临床试验批准的剂型为吸入粉雾剂。本次获批的临床适应症为间质性肺疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：高选择性PDE4B抑制剂(SYH2059吸入粉雾剂)在中国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0315179316.USD","LU1226287529.USD","LU1008478684.HKD","LU2039709279.SGD","LU1226288170.HKD","LU1960683339.HKD","SG9999004220.SGD","LU1152091754.HKD","LU1328277881.USD","LU0072913022.USD","IE00B543WZ88.USD","LU0140636845.USD","BK1521","IE0008368742.USD","LU0326950275.SGD","BK1515","LU1813983027.USD","LU1152091168.USD","LU1993786604.SGD","LU1951186391.HKD","01093","LU1226287875.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1807302812.USD","LU1226287792.SGD","LU0880133367.SGD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","HK0000165453.HKD","LU1226288253.USD","LU0501845795.SGD","BK1191","IE0008369823.USD","IE00BZ08YS42.EUR","IE00B031HY20.USD","LU0067412154.USD"],"gpt_icon":0},{"id":"2619535433","title":"石药集团等在海南成立医药科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2619535433","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619535433?lang=zh_cn&edition=full","pubTime":"2026-03-16 11:18","pubTimestamp":1773631098,"startTime":"0","endTime":"0","summary":"人民财讯3月16日电，企查查APP显示，近日，石药细胞谷（海南）医药科技有限公司成立，法定代表人为肖本景，注册资本2000万元，经营范围包含医疗服务；药品生产；生活美容服务；医学研究和试验发展；人体干细胞技术开发和应用等。企查查股权穿透显示，该公司由石药控股集团有限公司、深圳细胞谷生物医药有限公司等共同持股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603163672895546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2039709279.SGD","159938","LU0501845795.SGD","BK1515","BK1574","LU0880133367.SGD","BK1521","LU1960683339.HKD","LU1226288170.HKD","IE00B031HY20.USD","IE00B543WZ88.USD","LU0067412154.USD","LU1807302812.USD","LU0326950275.SGD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU0072913022.USD","LU0140636845.USD","LU0315179316.USD","LU1152091168.USD","LU1152091754.HKD","LU1226287529.USD","IE00BZ08YS42.EUR","01093","LU1951186391.HKD","BK1191","IE00BZ08YT58.USD","LU1813983027.USD","LU1008478684.HKD","IE00BZ08YR35.GBP","IE0008369823.USD","LU1328277881.USD","BK1161","HK0000165453.HKD","SG9999004220.SGD","09939","LU1993786604.SGD","LU1226287792.SGD","LU1226287875.USD","LU1226288253.USD","IE0008368742.USD"],"gpt_icon":0},{"id":"2619118735","title":"石药集团(01093.HK)拟3月25日举行董事会会议以审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619118735","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619118735?lang=zh_cn&edition=full","pubTime":"2026-03-13 21:47","pubTimestamp":1773409628,"startTime":"0","endTime":"0","summary":"格隆汇3月13日丨石药集团(01093.HK)公告，董事会会议将于2026年3月25日(星期三)举行，藉以(其中包括)批准公司及其附属公司截至2025年12月31日止年度全年业绩及考虑派发末期股息(如有)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260313/32067812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01093","BK1515","LU0067412154.USD","HK0000165453.HKD","LU1807302812.USD","LU2039709279.SGD","LU0315179316.USD","LU0326950275.SGD","LU0880133367.SGD","LU1226288170.HKD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU1152091168.USD","IE0008368742.USD","IE00B031HY20.USD","LU1226287792.SGD","IE0008369823.USD","IE00B543WZ88.USD","LU1813983027.USD","IE00BZ08YT58.USD","LU1226288253.USD","LU1328277881.USD","LU0314109678.HKD","LU1226287529.USD","LU1960683339.HKD","LU0140636845.USD","LU1226287875.USD","IE00BZ08YS42.EUR","LU1993786604.SGD","LU1152091754.HKD","IE00B5MMRT66.SGD","BK1521","LU1008478684.HKD","LU0501845795.SGD","LU0072913022.USD","BK1191","LU1951186391.HKD"],"gpt_icon":0},{"id":"2618568180","title":"石药集团03月12日主力净流出3656.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618568180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618568180?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:15","pubTimestamp":1773303357,"startTime":"0","endTime":"0","summary":"03月12日, 石药集团股价跌4.53%，报收8.65元，成交金额8.4亿元，换手率0.84%，振幅6.51%，量比1.16。石药集团今日主力资金净流出3656.7万元，上一交易日主力净流入649.0万元。该股近5个交易日下跌5.27%，主力资金累计净流入589.6万元；近20日主力资金累计净流入3.6亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312162101a4636850&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312162101a4636850&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1951186391.HKD","LU1226287792.SGD","LU0314109678.HKD","LU2039709279.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","LU0067412154.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1993786604.SGD","LU1807302812.USD","IE0008369823.USD","BK1515","LU1226287529.USD","LU1226288170.HKD","SG9999004220.SGD","LU1152091168.USD","LU0315179316.USD","IE00BZ08YR35.GBP","IE0008368742.USD","IE00BZ08YT58.USD","LU0140636845.USD","IE00B031HY20.USD","01093","LU0880133367.SGD","LU0501845795.SGD","LU1813983027.USD","LU1226288253.USD","BK1191","HK0000165453.HKD","IE00B543WZ88.USD","LU1226287875.USD","LU1960683339.HKD","BK1521","LU1328277881.USD","LU1008478684.HKD","LU0326950275.SGD"],"gpt_icon":0},{"id":"2618925480","title":"每日卖空追踪 | 石药集团 03月11日卖空量成交971.8万股，卖空比例为11.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925480","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618925480?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217819,"startTime":"0","endTime":"0","summary":"石药集团北京时间03月11日，跌2.16%，卖空量成交971.8万股，较上一交易日减少40.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163209a6b79373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163209a6b79373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B031HY20.USD","LU0315179316.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU1226287875.USD","LU1226288170.HKD","LU1328277881.USD","LU0067412154.USD","LU0072913022.USD","LU1807302812.USD","SG9999004220.SGD","IE00B543WZ88.USD","LU1152091754.HKD","BK1515","LU1813983027.USD","LU0140636845.USD","LU1226287529.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU1008478684.HKD","IE0008369823.USD","LU2039709279.SGD","IE0008368742.USD","LU1152091168.USD","IE00BZ08YR35.GBP","HK0000165453.HKD","IE00BZ08YS42.EUR","LU0880133367.SGD","01093","LU1226288253.USD","LU1951186391.HKD","LU0501845795.SGD","LU0326950275.SGD","BK1191","BK1521","LU1993786604.SGD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2618925435","title":"医药生物行业周报：罗伐昔替尼达成高额独家授权协议，创新药BD交易持续活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2618925435","media":"上海证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618925435?lang=zh_cn&edition=full","pubTime":"2026-03-11 14:05","pubTimestamp":1773209138,"startTime":"0","endTime":"0","summary":"主要观点2026年3月4日，中国生物制药宣布与赛诺菲就罗伐昔替尼达成独家授权协议。根据协议，中国生物制药子公司正大天晴授予赛诺菲在全球范围内开发、生产及商业化罗伐昔替尼的独家许可。四起交易均为临床前资产，彰显中国源头创新能力获全球认可。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031114054897ad2986&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031114054897ad2986&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287792.SGD","IE0008369823.USD","LU0326950275.SGD","LU1813983027.USD","LU0067412154.USD","LU0072913022.USD","BK1515","LU1152091754.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU0315179316.USD","LU1008478684.HKD","BK1574","IE00B543WZ88.USD","LU1226288170.HKD","HK0000165453.HKD","LU1807302812.USD","01093","01801","IE00BZ08YR35.GBP","06978","SG9999004220.SGD","LU0501845795.SGD","BK1521","IE00BZ08YS42.EUR","LU1226287875.USD","LU2039709279.SGD","IE00BZ08YT58.USD","IE0008368742.USD","LU1951186391.HKD","LU0880133367.SGD","BK1161","IE00B5MMRT66.SGD","LU1960683339.HKD","LU1226287529.USD","LU1152091168.USD","LU0314109678.HKD","01177","LU0140636845.USD","LU1226288253.USD","BK1191","LU1328277881.USD"],"gpt_icon":0},{"id":"2618951280","title":"每日卖空追踪 | 石药集团 03月10日卖空量成交790.4万股，卖空比例为10.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618951280?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:30","pubTimestamp":1773131418,"startTime":"0","endTime":"0","summary":"石药集团北京时间03月10日，涨1.2%，卖空量成交790.4万股，较上一交易日减少71.99%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163203a45df631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310163203a45df631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0880133367.SGD","LU0501845795.SGD","LU0067412154.USD","LU1813983027.USD","IE00B543WZ88.USD","LU1226287875.USD","LU0140636845.USD","LU1152091754.HKD","LU1328277881.USD","LU1226288170.HKD","SG9999004220.SGD","LU1226288253.USD","LU1960683339.HKD","IE00B031HY20.USD","LU0314109678.HKD","IE00BZ08YS42.EUR","01093","HK0000165453.HKD","LU0072913022.USD","LU1993786604.SGD","BK1191","IE00BZ08YR35.GBP","LU1226287529.USD","LU1951186391.HKD","LU2039709279.SGD","IE0008369823.USD","IE00BZ08YT58.USD","LU1008478684.HKD","LU1152091168.USD","LU1807302812.USD","BK1515","IE0008368742.USD","LU0315179316.USD","BK1521","LU0326950275.SGD","LU1226287792.SGD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2618238951","title":"石药集团03月10日主力净流入4999.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618238951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618238951?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:16","pubTimestamp":1773130566,"startTime":"0","endTime":"0","summary":"03月10日, 石药集团股价涨1.20%，报收9.26元，成交金额7.2亿元，换手率0.67%，振幅3.17%，量比0.90。石药集团今日主力资金净流入4999.1万元，上一交易日主力净流出2690.7万元。该股近5个交易日上涨1.19%，主力资金累计净流入5691.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4.1亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310162213a6b4cb42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310162213a6b4cb42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091168.USD","LU1328277881.USD","01093","LU1960683339.HKD","IE00BZ08YS42.EUR","IE0008368742.USD","IE00B031HY20.USD","LU0880133367.SGD","LU1226288170.HKD","LU0315179316.USD","LU1008478684.HKD","LU0501845795.SGD","LU1152091754.HKD","BK1191","HK0000165453.HKD","LU1951186391.HKD","LU1226287529.USD","SG9999004220.SGD","BK1521","IE00B543WZ88.USD","LU0072913022.USD","BK1515","LU1226287792.SGD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1993786604.SGD","IE0008369823.USD","LU2039709279.SGD","LU0140636845.USD","LU1226287875.USD","LU0067412154.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU0314109678.HKD","IE00BZ08YT58.USD","LU1226288253.USD"],"gpt_icon":0},{"id":"2618283951","title":"【瞩目】石药集团吸入剂大爆发，超200亿市场再掀波澜","url":"https://stock-news.laohu8.com/highlight/detail?id=2618283951","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618283951?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:04","pubTimestamp":1773129860,"startTime":"0","endTime":"0","summary":"茚达特罗莫米松吸入粉雾剂用于成人和12岁及以上青少年哮喘的维持治疗。石药集团表示，此次茚达特罗莫米松吸入粉雾剂获批临床，是集团高端创新吸入技术平台的又一重要成果，为管线内后续吸入制剂的开发奠定良好基础。3月6日，石药集团再发公告，集团开发的化药1类新药SYH2059吸入粉雾剂获美国FDA批准，可以在美国开展临床试验。在此之前，石药集团新品公告捷报频传。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031016320397abc96d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031016320397abc96d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","LU0314109678.HKD","LU1226287875.USD","LU0140636845.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1226288253.USD","BK1521","IE00B543WZ88.USD","LU0326950275.SGD","LU1152091754.HKD","LU0067412154.USD","HK0000165453.HKD","LU1226287792.SGD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1807302812.USD","LU1152091168.USD","LU0072913022.USD","IE00B5MMRT66.SGD","IE0008368742.USD","LU0880133367.SGD","LU1226287529.USD","IE00BZ08YS42.EUR","IE0008369823.USD","BK1191","BK1515","LU1813983027.USD","LU0501845795.SGD","LU1960683339.HKD","LU0315179316.USD","01093","LU1008478684.HKD","LU2039709279.SGD","SG9999004220.SGD","LU1328277881.USD","LU1226288170.HKD"],"gpt_icon":0},{"id":"2617682131","title":"石药集团(01093)：高选择性PDE4B抑制剂(SYH2059吸入粉雾剂)在美国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2617682131","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617682131?lang=zh_cn&edition=full","pubTime":"2026-03-06 19:44","pubTimestamp":1772797481,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的化药1类新药SYH2059吸入粉雾剂已获美国食品药品监督管理局批准，可在美国开展临床试验。该产品是集团一款全新的、具有完全自主知识产权的高活性与高选择性磷酸二酯酶4B抑制剂。本次获得临床试验批准的剂型为吸入粉雾剂。该产品获得临床试验批准，是集团高端创新吸入技术平台的重要成果，为管线内后续创新吸入制剂的开发奠定了良好基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411137.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：高选择性PDE4B抑制剂(SYH2059吸入粉雾剂)在美国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226287792.SGD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1152091754.HKD","LU1993786604.SGD","LU1328277881.USD","LU0880133367.SGD","BK1521","LU0072913022.USD","LU1226288170.HKD","LU1226288253.USD","SG9999004220.SGD","HK0000165453.HKD","LU0140636845.USD","01093","LU1960683339.HKD","LU0314109678.HKD","LU1226287875.USD","LU1008478684.HKD","BK1191","LU1813983027.USD","BK1515","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU0315179316.USD","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU0067412154.USD","LU1226287529.USD","LU1152091168.USD","LU0326950275.SGD","IE0008369823.USD","LU1807302812.USD"],"gpt_icon":0},{"id":"1143221509","title":"石药集团高选择性PDE4B抑制剂SYH2059吸入粉剂获美国临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1143221509","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143221509?lang=zh_cn&edition=full","pubTime":"2026-03-06 19:44","pubTimestamp":1772797453,"startTime":"0","endTime":"0","summary":"石药集团宣布，其研发的高选择性PDE4B抑制剂SYH2059吸入粉剂已获得美国监管机构的临床试验批准。这一进展标志着该创新药物正式进入国际临床开发阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1807302812.USD","IE00B543WZ88.USD","HK0000165453.HKD","LU1152091754.HKD","IE00BZ08YT58.USD","LU1226287875.USD","LU0072913022.USD","LU0315179316.USD","LU0067412154.USD","LU1226287529.USD","LU1813983027.USD","LU0326950275.SGD","LU1226287792.SGD","LU1951186391.HKD","LU1152091168.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","SG9999004220.SGD","LU1960683339.HKD","01093","LU1226288253.USD","LU1008478684.HKD","LU0880133367.SGD","IE00B031HY20.USD","LU0501845795.SGD","IE0008368742.USD","LU1993786604.SGD","BK1521","LU0314109678.HKD","IE00BZ08YR35.GBP","BK1191","LU1328277881.USD","BK1515","LU0140636845.USD","IE00BZ08YS42.EUR","IE0008369823.USD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2617540395","title":"智通港股解盘 | 突发霍尔木兹海峡有限放开 关注明日人大记者招待会","url":"https://stock-news.laohu8.com/highlight/detail?id=2617540395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617540395?lang=zh_cn&edition=full","pubTime":"2026-03-05 21:10","pubTimestamp":1772716245,"startTime":"0","endTime":"0","summary":"3 月 4 日，美国国会参议院对一项旨在限制总统战争权力的议案进行表决，该议案要求美国总统在进一步对伊朗采取军事行动前必须获得国会授权。然而下午发生突变：伊朗哈塔姆·安比亚中央司令部副司令阿米尔·海达里当地时间 5 日上午在接受采访时表示，伊朗方面并未封锁霍尔木兹海峡。其中年销售额超过 100 亿元的药品 40 余个。返程航班 CA790 计划于当地时间 3月 5 日 22:55 起飞，预计北京时间 3 月 6 日 12:52 飞抵北京。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1515","IE00BZ08YR35.GBP","LU1807302812.USD","LU0072913022.USD","LU1226287529.USD","BK1167","BK1521","BK4585","02038","BK1504","IE00BZ08YT58.USD","LU0501845795.SGD","IE00B5MMRT66.SGD","LU1008478684.HKD","LU1152091168.USD","LU1813983027.USD","BK4588","01093","LU1993786604.SGD","LU0880133367.SGD","LU1951186391.HKD","IE00B031HY20.USD","IE00B543WZ88.USD","LU1226288253.USD","LU2039709279.SGD","SG9999004220.SGD","LU0314109678.HKD","02196","LU0315179316.USD","BK1508","IE0008369823.USD","BK1191","LU0067412154.USD","LU1226287792.SGD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU1226288170.HKD","HK0000165453.HKD","LU1152091754.HKD","LU1226287875.USD","IE0008368742.USD","VXUS","LU1328277881.USD","VT","LU0326950275.SGD","LU0140636845.USD"],"gpt_icon":0},{"id":"2617546501","title":"石药集团(01093)：茚达特罗莫米松吸入粉雾剂在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2617546501","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617546501?lang=zh_cn&edition=full","pubTime":"2026-03-05 19:16","pubTimestamp":1772709413,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的茚达特罗莫米松吸入粉雾剂已获中国国家药品监督管理局批准，可在中国开展临床试验。该产品用于成人和12岁及以上青少年哮喘的维持治疗。茚达特罗莫米松吸入粉雾剂是首个纳入《国家医保目录》中可一天一次使用的吸入ICS-LABA二联复方吸入制剂，为哮喘患者提供了更高效、更便捷的治疗选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石药集团(01093)：茚达特罗莫米松吸入粉雾剂在中国获临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0008368742.USD","BK1521","BK1191","IE0008369823.USD","IE00BZ08YS42.EUR","SG9999004220.SGD","IE00B543WZ88.USD","LU0140636845.USD","LU0326950275.SGD","LU1993786604.SGD","LU1226287875.USD","IE00B5MMRT66.SGD","LU0315179316.USD","LU1008478684.HKD","LU1328277881.USD","IE00BZ08YT58.USD","LU2039709279.SGD","LU1226287529.USD","LU0072913022.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1226288253.USD","LU1813983027.USD","BK1515","LU1152091168.USD","01093","LU1960683339.HKD","LU1226288170.HKD","LU0067412154.USD","HK0000165453.HKD","LU0880133367.SGD","LU1807302812.USD","LU1951186391.HKD","LU0314109678.HKD","LU1152091754.HKD","LU0501845795.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":0.0244},{"period":"1month","weight":-0.1415},{"period":"3month","weight":0.0732},{"period":"6month","weight":-0.1011},{"period":"1year","weight":0.7471},{"period":"ytd","weight":0.0439}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0535},{"period":"3month","weight":-0.0161},{"period":"6month","weight":-0.0478},{"period":"1year","weight":0.0437},{"period":"ytd","weight":-0.0138}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石药集团有限公司是一家主要从事生产及销售药品的投资控股公司。该公司通过三个分部运营其业务。成药分部从事研发、生产及销售药品以及授权业务。原料产品分部从事生产及销售粉状维生素C及抗生素产品。功能食品及其他分部从事制造及销售功能食品产品（包括咖啡因食物添加剂、无水葡萄糖、阿卡波糖及维生素C含片）、提供医疗服务及其他。该公司的产品治疗领域包括神经系统、抗肿瘤、抗感染、心血管、呼吸系统、消化代谢等其他领域。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.094687},{"month":3,"riseRate":0.46875,"avgChangeRate":0.016376},{"month":4,"riseRate":0.612903,"avgChangeRate":0.062074},{"month":5,"riseRate":0.612903,"avgChangeRate":0.047434},{"month":6,"riseRate":0.322581,"avgChangeRate":0.003636},{"month":7,"riseRate":0.375,"avgChangeRate":0.009082},{"month":8,"riseRate":0.4375,"avgChangeRate":0.010009},{"month":9,"riseRate":0.5,"avgChangeRate":0.000153},{"month":10,"riseRate":0.5625,"avgChangeRate":0.010484},{"month":11,"riseRate":0.46875,"avgChangeRate":0.00638},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013271}],"exchange":"SEHK","name":"石药集团","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石药集团,01093,石药集团股票,石药集团股票老虎,石药集团股票老虎国际,石药集团行情,石药集团股票行情,石药集团股价,石药集团股市,石药集团股票价格,石药集团股票交易,石药集团股票购买,石药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石药集团(01093)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石药集团(01093)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}